Among them, TEAD4 (HR = 1.074) and CIT (HR = 1.595) are risk factors for the prognosis of HCC, and their high expression leads to poor prognosis of HCC, while SOCS2 (HR = 0.791) is a protective factor, and its high expression improves the prognosis of HCC patients (Fig. 1N–P). Here, TEAD4 is linked to hepatocellular carcinoma.